Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2009

Open Access 01-12-2009 | Original investigation

Associations of cardiovascular risk factors in Al Ain- United Arab Emirates

Authors: Latifa M Baynouna, Anthony D Revel, Nico JD Nagelkerke, Tariq M Jaber, Aziza O Omar, Nader M Ahmed, Mohammad K Nazirudeen, Mamdouh F Al Sayed, Fuad A Nour, Sameh Abdouni

Published in: Cardiovascular Diabetology | Issue 1/2009

Login to get access

Abstract

Background

Over the last 30 years the citizens of the United Arab Emirates have experienced major changes in life-style secondary to increased affluence. Currently, 1 in 5 adults have diabetes mellitus, but the associations (clustering) among risk factors, as well as the relevance of the concept of the metabolic syndrome, in this population is unknown.

Aim

To investigate the prevalence and associations among cardiovascular risk factors in this population, and explore to what extent associations can be explained by the metabolic syndrome according to ATP-III criteria.

Method

A community based survey, of conventional risk factors for cardiovascular disease was conducted among 817 national residents of Al Ain city, UAE. These factors were fasting blood sugar, blood pressure, lipid profile, BMI, waist circumference, smoking, or CHD family history. Odds ratios between risks factors, both unadjusted and adjusted for age and sex as well as adjusted for age, sex, and metabolic syndrome were calculated.

Results

Various risk factors were positively associated in this population; associations that are mostly unexplained by confounding by age and sex. For example, hypertension and diabetes were still strongly related (OR 2.5; 95% CI 1.7–3.7) after adjustment. An increased waist circumference showed similar relationship with hypertension (OR 2.3; 95% CI 1.5–3.5). Diabetes was related to an increased BMI (OR 1.5; 96% CI 1.0–2.3). Smoking was also associated with diabetes (OR 1.9, 95% CI 1.0–3.3).
Further adjustment for metabolic syndrome reduced some associations but several remained.

Conclusion

In this population risk-factors cluster, but associations do not appear to be explained by the presence/absence of the ATP-III metabolic syndrome. Associations provide valuable information in planning interventions for screening and management.
Appendix
Available only for authorised users
Literature
1.
go back to reference Baynouna LM, Revel AD, Nagelkerke NJ, Jaber TM, Omar AO, Ahmed NM, Naziruldeen MK, Al-Sayed MF, Nour FA: High prevalence of the cardiovascular risk factors in Al-Ain, United Arab Emirates. An emerging health care priority. Saudi Med J. 2008, 29 (8): 1173-1178.PubMed Baynouna LM, Revel AD, Nagelkerke NJ, Jaber TM, Omar AO, Ahmed NM, Naziruldeen MK, Al-Sayed MF, Nour FA: High prevalence of the cardiovascular risk factors in Al-Ain, United Arab Emirates. An emerging health care priority. Saudi Med J. 2008, 29 (8): 1173-1178.PubMed
2.
go back to reference Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, Howard BV: A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study. Hypertension. 2006, 47 (3): 403-409. 10.1161/01.HYP.0000200710.29498.80.CrossRefPubMed Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, Howard BV: A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study. Hypertension. 2006, 47 (3): 403-409. 10.1161/01.HYP.0000200710.29498.80.CrossRefPubMed
3.
go back to reference Tohme RA, Jurjus AR, Estephan A: The prevalence of hypertension and its association with other cardiovascular disease risk factors in a representative sample of the Lebanese population. J Hum Hypertens. 2005, 19 (11): 861-868. 10.1038/sj.jhh.1001909.CrossRefPubMed Tohme RA, Jurjus AR, Estephan A: The prevalence of hypertension and its association with other cardiovascular disease risk factors in a representative sample of the Lebanese population. J Hum Hypertens. 2005, 19 (11): 861-868. 10.1038/sj.jhh.1001909.CrossRefPubMed
4.
go back to reference Shapo L, Pomerleau J, McKee M: Epidemiology of hypertension and associated cardiovascular risk factors in a country in transition: a population based survey in Tirana City, Albania. J Epidemiol Community Health. 2003, 57 (9): 734-739. 10.1136/jech.57.9.734.PubMedCentralCrossRefPubMed Shapo L, Pomerleau J, McKee M: Epidemiology of hypertension and associated cardiovascular risk factors in a country in transition: a population based survey in Tirana City, Albania. J Epidemiol Community Health. 2003, 57 (9): 734-739. 10.1136/jech.57.9.734.PubMedCentralCrossRefPubMed
5.
go back to reference Borde-Perry WC, Campbell KL, Murtaugh KH, Gidding S, Falkner B: The association between hypertension and other cardiovascular risk factors in young adult African Americans. J Clin Hypertens (Greenwich). 2002, 4 (1): 17-22. 10.1111/j.1524-6175.2002.01211.x.CrossRef Borde-Perry WC, Campbell KL, Murtaugh KH, Gidding S, Falkner B: The association between hypertension and other cardiovascular risk factors in young adult African Americans. J Clin Hypertens (Greenwich). 2002, 4 (1): 17-22. 10.1111/j.1524-6175.2002.01211.x.CrossRef
6.
go back to reference Li W, Ma D, Liu M, Liu H, Feng S, Hao Z, Wu B, Zhang S: Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis. 2008, 25 (6): 539-547. 10.1159/000131672.CrossRefPubMed Li W, Ma D, Liu M, Liu H, Feng S, Hao Z, Wu B, Zhang S: Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis. 2008, 25 (6): 539-547. 10.1159/000131672.CrossRefPubMed
7.
go back to reference Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007, 49 (4): 403-414. 10.1016/j.jacc.2006.09.032.CrossRefPubMed Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007, 49 (4): 403-414. 10.1016/j.jacc.2006.09.032.CrossRefPubMed
8.
go back to reference Galassi A, Reynolds K, He J: Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006, 119 (10): 812-819. 10.1016/j.amjmed.2006.02.031.CrossRefPubMed Galassi A, Reynolds K, He J: Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006, 119 (10): 812-819. 10.1016/j.amjmed.2006.02.031.CrossRefPubMed
9.
go back to reference Reaven GM: The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr. 2006, 83 (6): 1237-1247.PubMed Reaven GM: The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr. 2006, 83 (6): 1237-1247.PubMed
10.
go back to reference Yarnell JW, Patterson CC, Bainton D, Sweetnam PM: Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. Heart. 1998, 79 (3): 248-252.PubMedCentralCrossRefPubMed Yarnell JW, Patterson CC, Bainton D, Sweetnam PM: Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. Heart. 1998, 79 (3): 248-252.PubMedCentralCrossRefPubMed
11.
go back to reference Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005, 28 (9): 2289-2304. 10.2337/diacare.28.9.2289.CrossRefPubMed Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005, 28 (9): 2289-2304. 10.2337/diacare.28.9.2289.CrossRefPubMed
12.
go back to reference Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG: Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med. 2008, 35 (4): 357-363. 10.1016/j.amepre.2008.06.035.PubMedCentralCrossRefPubMed Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG: Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med. 2008, 35 (4): 357-363. 10.1016/j.amepre.2008.06.035.PubMedCentralCrossRefPubMed
13.
go back to reference Seidel MC, Powell RO, Zgibor JC, Siminerio LM, Piatt GA: Translating the Diabetes Prevention Program into an urban medically underserved community: a nonrandomized prospective intervention study. Diabetes Care. 2008, 31 (4): 684-689. 10.2337/dc07-1869.CrossRefPubMed Seidel MC, Powell RO, Zgibor JC, Siminerio LM, Piatt GA: Translating the Diabetes Prevention Program into an urban medically underserved community: a nonrandomized prospective intervention study. Diabetes Care. 2008, 31 (4): 684-689. 10.2337/dc07-1869.CrossRefPubMed
14.
go back to reference Ackermann RT, Marrero DG: Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ. 2007, 33 (1): 69-10.1177/0145721706297743. 74-69, 78.CrossRefPubMed Ackermann RT, Marrero DG: Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ. 2007, 33 (1): 69-10.1177/0145721706297743. 74-69, 78.CrossRefPubMed
16.
go back to reference Al-Kaabi J, Al-Maskari F, Saadi H, Afandi B, Parkar H, Nagelkerke N: Assessment of dietary practice among diabetic patients in the United arab emirates. Rev Diabet Stud. 2008, 5 (2): 110-115. 10.1900/RDS.2008.5.110.PubMedCentralCrossRefPubMed Al-Kaabi J, Al-Maskari F, Saadi H, Afandi B, Parkar H, Nagelkerke N: Assessment of dietary practice among diabetic patients in the United arab emirates. Rev Diabet Stud. 2008, 5 (2): 110-115. 10.1900/RDS.2008.5.110.PubMedCentralCrossRefPubMed
17.
go back to reference Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, Lukic M, Nicholls MG, Kazam E, Algawi K, Al-Kaabi J, Leduc C, Sabri S, El-Sadig M, Elkhumaidi S, Agarwal M, Benedict S: Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract. 2007, 78 (3): 369-377. 10.1016/j.diabres.2007.04.008.CrossRefPubMed Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, Lukic M, Nicholls MG, Kazam E, Algawi K, Al-Kaabi J, Leduc C, Sabri S, El-Sadig M, Elkhumaidi S, Agarwal M, Benedict S: Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract. 2007, 78 (3): 369-377. 10.1016/j.diabres.2007.04.008.CrossRefPubMed
18.
go back to reference Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P: Increasing prevalence of diabetes mellitus in Oman. Diabet Med. 2002, 19 (11): 954-957. 10.1046/j.1464-5491.2002.00818.x.CrossRefPubMed Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P: Increasing prevalence of diabetes mellitus in Oman. Diabet Med. 2002, 19 (11): 954-957. 10.1046/j.1464-5491.2002.00818.x.CrossRefPubMed
19.
go back to reference Gunaid AA: Prevalence of known diabetes and hypertension in the Republic of Yemen. East Mediterr Health J. 2002, 8 (2–3): 374-385.PubMed Gunaid AA: Prevalence of known diabetes and hypertension in the Republic of Yemen. East Mediterr Health J. 2002, 8 (2–3): 374-385.PubMed
20.
go back to reference Weingarten MA, Katzir I, Sprecher E, Kobzantsev S, Zelzer C, Kahan E: Diabetes and ischemic heart disease among Yemenite immigrants in Israel. Isr Med Assoc J. 2000, 2 (3): 207-210.PubMed Weingarten MA, Katzir I, Sprecher E, Kobzantsev S, Zelzer C, Kahan E: Diabetes and ischemic heart disease among Yemenite immigrants in Israel. Isr Med Assoc J. 2000, 2 (3): 207-210.PubMed
21.
go back to reference The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2008 The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2008
22.
go back to reference Vazquez G, Duval S, Jacobs DR, Silventoinen K: Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007, 29: 115-128. 10.1093/epirev/mxm008.CrossRefPubMed Vazquez G, Duval S, Jacobs DR, Silventoinen K: Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007, 29: 115-128. 10.1093/epirev/mxm008.CrossRefPubMed
23.
go back to reference Nyamdorj R, Qiao Q, Lam TH: BMI compared with central obesity indicators in relation to diabetes and hypertension in Asians. Obesity (Silver Spring). 2008, 16 (7): 1622-1635. 10.1038/oby.2008.73.CrossRef Nyamdorj R, Qiao Q, Lam TH: BMI compared with central obesity indicators in relation to diabetes and hypertension in Asians. Obesity (Silver Spring). 2008, 16 (7): 1622-1635. 10.1038/oby.2008.73.CrossRef
24.
go back to reference Is central obesity a better discriminator of the risk of hypertension than body mass index in ethnically diverse populations?. J Hypertens. 2008, 26 (2): 169-177. 10.1097/HJH.0b013e3282f16ad3. Is central obesity a better discriminator of the risk of hypertension than body mass index in ethnically diverse populations?. J Hypertens. 2008, 26 (2): 169-177. 10.1097/HJH.0b013e3282f16ad3.
25.
go back to reference Ghoddusi K, Ameli J, Kachuee H, Pourfarziani V, Saadat A, Karami Q: Association of diabetes mellitus and dyslipidaemias in the Tehran population. East Mediterr Health J. 2008, 14 (3): 647-653.PubMed Ghoddusi K, Ameli J, Kachuee H, Pourfarziani V, Saadat A, Karami Q: Association of diabetes mellitus and dyslipidaemias in the Tehran population. East Mediterr Health J. 2008, 14 (3): 647-653.PubMed
26.
go back to reference Radzeviciene L, Ostrauskas R: [Smoking and type 2 diabetes mellitus]. Medicina (Kaunas). 2006, 42 (7): 559-565. Radzeviciene L, Ostrauskas R: [Smoking and type 2 diabetes mellitus]. Medicina (Kaunas). 2006, 42 (7): 559-565.
27.
go back to reference Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH: A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med. 2000, 109 (7): 538-542. 10.1016/S0002-9343(00)00568-4.CrossRefPubMed Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH: A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med. 2000, 109 (7): 538-542. 10.1016/S0002-9343(00)00568-4.CrossRefPubMed
28.
go back to reference Hayashino Y, Fukuhara S, Okamura T, Yamato H, Tanaka H, Tanaka T, Kadowaki T, Ueshima H: A prospective study of passive smoking and risk of diabetes in a cohort of workers: the High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Diabetes Care. 2008, 31 (4): 732-734. 10.2337/dc07-1905.CrossRefPubMed Hayashino Y, Fukuhara S, Okamura T, Yamato H, Tanaka H, Tanaka T, Kadowaki T, Ueshima H: A prospective study of passive smoking and risk of diabetes in a cohort of workers: the High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Diabetes Care. 2008, 31 (4): 732-734. 10.2337/dc07-1905.CrossRefPubMed
29.
go back to reference Suzuki Y, Kuwajima I, Kuramoto K, Otsuka K: [Age and gender difference in circadian rhythm in blood pressure]. Nippon Ronen Igakkai Zasshi. 1993, 30 (9): 778-786.CrossRefPubMed Suzuki Y, Kuwajima I, Kuramoto K, Otsuka K: [Age and gender difference in circadian rhythm in blood pressure]. Nippon Ronen Igakkai Zasshi. 1993, 30 (9): 778-786.CrossRefPubMed
30.
go back to reference El-Hazmi MA, Warsy AS: Association of hypertension and non-insulin-dependent diabetes mellitus in the Saudi population. Ann Saudi Med. 2001, 21 (1–2): 5-8.PubMed El-Hazmi MA, Warsy AS: Association of hypertension and non-insulin-dependent diabetes mellitus in the Saudi population. Ann Saudi Med. 2001, 21 (1–2): 5-8.PubMed
31.
go back to reference Benetos A, Thomas F, Pannier B, Bean K, Jego B, Guize L: All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am J Cardiol. 2008, 102 (2): 188-191. 10.1016/j.amjcard.2008.03.037.CrossRefPubMed Benetos A, Thomas F, Pannier B, Bean K, Jego B, Guize L: All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am J Cardiol. 2008, 102 (2): 188-191. 10.1016/j.amjcard.2008.03.037.CrossRefPubMed
Metadata
Title
Associations of cardiovascular risk factors in Al Ain- United Arab Emirates
Authors
Latifa M Baynouna
Anthony D Revel
Nico JD Nagelkerke
Tariq M Jaber
Aziza O Omar
Nader M Ahmed
Mohammad K Nazirudeen
Mamdouh F Al Sayed
Fuad A Nour
Sameh Abdouni
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2009
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-8-21

Other articles of this Issue 1/2009

Cardiovascular Diabetology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.